-
2
-
-
84857073798
-
Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis
-
M.Bodmer, C.Becker, C.Meier, S.S.Jick, C.R.Meier 2012. Use of metformin is not associated with a decreased risk of colorectal cancer:a case-control analysis. Cancer Epidemiol Biomarkers Prev. 21:280–286.
-
(2012)
Cancer Epidemiol Biomarkers Prev
, vol.21
, pp. 280-286
-
-
Bodmer, M.1
Becker, C.2
Meier, C.3
Jick, S.S.4
Meier, C.R.5
-
3
-
-
84991494403
-
Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study
-
M.Cardel, S.M.Jensen, A.Pottegard, T.L.Jorgensen, J.Hallas 2014. Long-term use of metformin and colorectal cancer risk in type II diabetics:a population-based case-control study. Cancer Med. 3:1458–1466.
-
(2014)
Cancer Med
, vol.3
, pp. 1458-1466
-
-
Cardel, M.1
Jensen, S.M.2
Pottegard, A.3
Jorgensen, T.L.4
Hallas, J.5
-
4
-
-
43049089327
-
Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea
-
Y.W.Chung, D.S.Han, K.H.Park, C.S.Eun, K.S.Yoo, C.K.Park 2008. Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus:a case-control study in Korea. Dis Colon Rectum. 51:593–597.
-
(2008)
Dis Colon Rectum
, vol.51
, pp. 593-597
-
-
Chung, Y.W.1
Han, D.S.2
Park, K.H.3
Eun, C.S.4
Yoo, K.S.5
Park, C.K.6
-
5
-
-
68449094325
-
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
-
C.J.Currie, C.D.Poole, E.A.Gale 2009. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 52:1766–1777.
-
(2009)
Diabetologia
, vol.52
, pp. 1766-1777
-
-
Currie, C.J.1
Poole, C.D.2
Gale, E.A.3
-
6
-
-
78649302320
-
Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis
-
A.Decensi, M.Puntoni, P.Goodwin, M.Cazzaniga, A.Gennari, B.Bonanni, S.Gandini 2010. Metformin and cancer risk in diabetic patients:a systematic review and meta-analysis. Cancer Prev Res (Phila). 3:1451–1461.
-
(2010)
Cancer Prev Res (Phila)
, vol.3
, pp. 1451-1461
-
-
Decensi, A.1
Puntoni, M.2
Goodwin, P.3
Cazzaniga, M.4
Gennari, A.5
Bonanni, B.6
Gandini, S.7
-
7
-
-
84907296915
-
Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders
-
S.Gandini, M.Puntoni, B.M.Heckman-Stoddard, B.K.Dunn, L.Ford, A.Decensi, E.Szabo 2014. Metformin and cancer risk and mortality:a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res (Phila). 7:867–885.
-
(2014)
Cancer Prev Res (Phila)
, vol.7
, pp. 867-885
-
-
Gandini, S.1
Puntoni, M.2
Heckman-Stoddard, B.M.3
Dunn, B.K.4
Ford, L.5
Decensi, A.6
Szabo, E.7
-
8
-
-
40349105880
-
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review
-
E.Giovannucci 2007. Metabolic syndrome, hyperinsulinemia, and colon cancer:a review. Am J Clin Nutr. 86:s836–s842.
-
(2007)
Am J Clin Nutr
, vol.86
, pp. s836-s842
-
-
Giovannucci, E.1
-
9
-
-
33847072201
-
AMP-activated protein kinase as a drug target
-
D.G.Hardie 2007. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol. 47:185–210.
-
(2007)
Annu Rev Pharmacol Toxicol
, vol.47
, pp. 185-210
-
-
Hardie, D.G.1
-
10
-
-
84863683395
-
The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese
-
M.C.Hsieh, T.C.Lee, S.M.Cheng, S.T.Tu, M.H.Yen, C.H.Tseng 2012. The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res. 2012:413782.
-
(2012)
Exp Diabetes Res
, vol.2012
, pp. 413782
-
-
Hsieh, M.C.1
Lee, T.C.2
Cheng, S.M.3
Tu, S.T.4
Yen, M.H.5
Tseng, C.H.6
-
11
-
-
40349112853
-
Metabolic syndrome, hyperinsulinemia, and cancer
-
I.R.Hsu, S.P.Kim, M.Kabir, R.N.Bergman 2007. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr. 86:s867–s871.
-
(2007)
Am J Clin Nutr
, vol.86
, pp. s867-s871
-
-
Hsu, I.R.1
Kim, S.P.2
Kabir, M.3
Bergman, R.N.4
-
12
-
-
0345167800
-
TSC2 mediates cellular energy response to control cell growth and survival
-
K.Inoki, T.Zhu, K.L.Guan 2003. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 115:577–590.
-
(2003)
Cell
, vol.115
, pp. 577-590
-
-
Inoki, K.1
Zhu, T.2
Guan, K.L.3
-
13
-
-
0031695628
-
Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link?
-
Y.I.Kim 1998. Diet, lifestyle, and colorectal cancer:is hyperinsulinemia the missing link? Nutr Rev. 56:275–279.
-
(1998)
Nutr Rev
, vol.56
, pp. 275-279
-
-
Kim, Y.I.1
-
14
-
-
27944450832
-
Diabetes mellitus and risk of colorectal cancer: a meta-analysis
-
S.C.Larsson, N.Orsini, A.Wolk 2005. Diabetes mellitus and risk of colorectal cancer:a meta-analysis. J Natl Cancer Inst. 97:1679–1687.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1679-1687
-
-
Larsson, S.C.1
Orsini, N.2
Wolk, A.3
-
15
-
-
78651451726
-
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
-
M.S.Lee, C.C.Hsu, M.L.Wahlqvist, H.N.Tsai, Y.H.Chang, Y.C.Huang 2011. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese:a representative population prospective cohort study of 800,000 individuals. BMC Cancer. 11:20.
-
(2011)
BMC Cancer
, vol.11
, pp. 20
-
-
Lee, M.S.1
Hsu, C.C.2
Wahlqvist, M.L.3
Tsai, H.N.4
Chang, Y.H.5
Huang, Y.C.6
-
16
-
-
69549097703
-
New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes
-
G.Libby, L.A.Donnelly, P.T.Donnan, D.R.Alessi, A.D.Morris, J.M.Evans 2009. New users of metformin are at low risk of incident cancer:a cohort study among people with type 2 diabetes. Diabetes Care. 32:1620–1625.
-
(2009)
Diabetes Care
, vol.32
, pp. 1620-1625
-
-
Libby, G.1
Donnelly, L.A.2
Donnan, P.T.3
Alessi, D.R.4
Morris, A.D.5
Evans, J.M.6
-
17
-
-
84858695046
-
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
-
H.Noto, A.Goto, T.Tsujimoto, M.Noda 2012. Cancer risk in diabetic patients treated with metformin:a systematic review and meta-analysis. PLoS One. 7:e33411.
-
(2012)
PLoS One
, vol.7
, pp. e33411
-
-
Noto, H.1
Goto, A.2
Tsujimoto, T.3
Noda, M.4
-
19
-
-
84859076050
-
Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study
-
R.Ruiter, L.E.Visser, M.P.van Herk-Sukel, J.W.Coebergh, H.R.Haak, P.H.Geelhoed-Duijvestijn, S.M.Straus, R.M.Herings, B.H.Stricker 2012. Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives:results from a large population-based follow-up study. Diabetes Care. 35:119–124.
-
(2012)
Diabetes Care
, vol.35
, pp. 119-124
-
-
Ruiter, R.1
Visser, L.E.2
van Herk-Sukel, M.P.3
Coebergh, J.W.4
Haak, H.R.5
Geelhoed-Duijvestijn, P.H.6
Straus, S.M.7
Herings, R.M.8
Stricker, B.H.9
-
21
-
-
84862848716
-
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis
-
D.Soranna, L.Scotti, A.Zambon, C.Bosetti, G.Grassi, A.Catapano, C.La Vecchia, G.Mancia, G.Corrao 2012. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes:a meta-analysis. Oncologist. 17:813–822.
-
(2012)
Oncologist
, vol.17
, pp. 813-822
-
-
Soranna, D.1
Scotti, L.2
Zambon, A.3
Bosetti, C.4
Grassi, G.5
Catapano, A.6
La Vecchia, C.7
Mancia, G.8
Corrao, G.9
-
22
-
-
33847080728
-
AMP-activated protein kinase in metabolic control and insulin signaling
-
M.C.Towler, D.G.Hardie 2007. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 100:328–341.
-
(2007)
Circ Res
, vol.100
, pp. 328-341
-
-
Towler, M.C.1
Hardie, D.G.2
-
23
-
-
84906691535
-
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical practice research datalink analyzed like an intention-to-treat trial
-
K.K.Tsilidis, D.Capothanassi, N.E.Allen, E.C.Rizos, D.S.Lopez, K.van Veldhoven, C.Sacerdote, D.Ashby, P.Vineis, I.Tzoulaki,. 2014. Metformin does not affect cancer risk:a cohort study in the U.K. Clinical practice research datalink analyzed like an intention-to-treat trial. Diabetes Care. 37:2522–2532.
-
(2014)
Diabetes Care
, vol.37
, pp. 2522-2532
-
-
Tsilidis, K.K.1
Capothanassi, D.2
Allen, N.E.3
Rizos, E.C.4
Lopez, D.S.5
van Veldhoven, K.6
Sacerdote, C.7
Ashby, D.8
Vineis, P.9
Tzoulaki, I.10
-
24
-
-
84990962502
-
-
G.Wells, B.Shea, D.O’Connell, J.Peterson, V.Welch, M.Losos, P.Tugwell (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; [cited 2014]. Available from:http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
-
(2011)
-
-
Wells, G.1
Shea, B.2
O’Connell, D.3
Peterson, J.4
Welch, V.5
Losos, M.6
Tugwell, P.7
-
25
-
-
84928658794
-
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
-
H.Xu, M.C.Aldrich, Q.Chen, H.Liu, N.B.Peterson, Q.Dai, M.Levy, A.Shah, X.Han, X.Ruan,. 2014. Validating drug repurposing signals using electronic health records:a case study of metformin associated with reduced cancer mortality. J Am Med Inform Assoc. 22:179–191.
-
(2014)
J Am Med Inform Assoc
, vol.22
, pp. 179-191
-
-
Xu, H.1
Aldrich, M.C.2
Chen, Q.3
Liu, H.4
Peterson, N.B.5
Dai, Q.6
Levy, M.7
Shah, A.8
Han, X.9
Ruan, X.10
-
26
-
-
5144234027
-
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
-
Y.X.Yang, S.Hennessy, J.D.Lewis 2004. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology. 127:1044–1050.
-
(2004)
Gastroenterology
, vol.127
, pp. 1044-1050
-
-
Yang, Y.X.1
Hennessy, S.2
Lewis, J.D.3
-
27
-
-
84858693012
-
Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis
-
Z.J.Zhang, Z.J.Zheng, H.Kan, Y.Song, W.Cui, G.Zhao, K.E.Kip 2011. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes:a meta-analysis. Diabetes Care. 34:2323–2328.
-
(2011)
Diabetes Care
, vol.34
, pp. 2323-2328
-
-
Zhang, Z.J.1
Zheng, Z.J.2
Kan, H.3
Song, Y.4
Cui, W.5
Zhao, G.6
Kip, K.E.7
-
28
-
-
84919922823
-
Colorectal cancer incidence and mortality in china, 2010
-
Z.X.Zheng, R.S.Zheng, S.W.Zhang, W.Q.Chen 2014. Colorectal cancer incidence and mortality in china, 2010. Asian Pac J Cancer Prev. 15:8455–8460.
-
(2014)
Asian Pac J Cancer Prev
, vol.15
, pp. 8455-8460
-
-
Zheng, Z.X.1
Zheng, R.S.2
Zhang, S.W.3
Chen, W.Q.4
|